Rohit Bose MD PhD

Genitourinary Oncology

Assistant Professor and Genitourinary Medical Oncologist at UCSF. Member of the Helen Diller Family Comprehensive Cancer Center.

Join to view full profile

1825 Fourth St.San Francisco, CA 94158
Phone+1 415-476-4616
Fax+1 415-353-7107

Dr. Bose is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bose's full profile Already have an account?

Summary

Dr. Rohit Bose is an oncologist specializing in genitourinary oncology based in San Francisco, CA. He holds an assistant professorship at UCSF Medical Center and previously served as an instructor at Memorial Sloan Kettering Cancer Center. Dr. Bose completed his fellowship in hematology and medical oncology at Memorial Sloan Kettering and his residency in internal medicine at New York Presbyterian Hospital. He obtained his MD PhD from the University of Toronto Faculty of Medicine. His research focuses on prostate cancer, with multiple publications in prominent journals like The Lancet Oncology and Cancer Medicine. He has received several awards, including the Young Investigator Award from the Prostate Cancer Foundation and the American Society of Clinical Oncology.

Rohit Bose Lab @ UCSF

The principal investigator of the lab is Rohit Bose MD PhD , assistant professor and practicing genitourinary medical oncologist at the UCSF Helen Diller Family

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2010
University of Toronto Faculty of MedicineClass of 2008, MD PhD

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2018 - 2028
NY State Medical License 2014 - 2018
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Young Investigator Award Prostate Cancer Foundation, 2016
Merit Award, Genitourinary Cancers Symposium American Society of Clinical Oncology, 2016
Physician Research Training Award US Department of Defense, Prostate Cancer Program, 2015

Publications & Presentations

PubMed

7 citations
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data.
Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen
European Urology Oncology. 2025-04-01
3 citations
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer.
Daniel H Kwon, Lauren Trihy, Nika Darvish, Eliza Hearst, Saffanat Sumra
Cancer Medicine. 2024-11-01
56 citations
Single-doseLu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 t...
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, Vadim Koshkin, Rohit Bose
The Lancet. Oncology. 2023-11-01

Journal Articles

ERF mutations reveal balance of positive and negative ETS factors controlling prostate cancer
Bose R, Karthaus W, Armenia J, Abida W, Iaquinta P, Wongvipat J, Wasmuth E, Shah N, Doran M, Wang P, Sullivan P, Patruno A, International SU2C/PCF Prostate Cancer Drea..., Nature, 1/1/2017
Income and spending patterns among panhandlers
Bose, R. and Hwang, S.W., Canadian Medical Association Journal, 1/1/2002
Spectroscopic characterization by laser flash photolysis of electrophilic intermediates derived from 4-aminostilbenes Stilbene nitrenium ions and quinone methide imines
Bose, R., Ahmad, A., Dicks, A., Kayser, K. and McClelland, R., Perkin Transactions, 1/1/1999

Books/Book Chapters

Functioning of Transmembrane Receptors in Signaling Mechanisms: Cell Signaling Collection
Chapter: TGFbeta Signal Transduction
Silvestri, C., Bose, R., Attisano, L. and Wrana, J.L.2010
Smad Signal Transduction
Chapter: Trafficking of Serine/Threonine Kinase Receptors and Smad Activation
Page 177 - 191Le Roy, C., Bose, R. and Wrana, J.LSpringer, Netherlands2006

Abstracts/Posters

Randomized Phase IB/II Study of Enzalutamide with and without Ribociclib in Patients with Metastatic Castrate Resistant, Chemotherapy Naive Prostate Cancer that Retain...
Kelly, W, Godwin J, Hoffman-Censits J, Knudsen K, De Leeuw R, Leiby B, Southwell T, Hubert C, Smith D, Chatta G, Aghalar J, Scher H, Bose R, Autio K, Abida W, Slovin S..., GU ASCO, San Francisco, 1/1/2018

Press Mentions

$35M Gift from Benioffs to Support Prostate Cancer Research Initiative at UCSFOctober 10th, 2019
UCSF Launches New Initiative to Accelerate Prostate Cancer ResearchSeptember 23rd, 2019
Researchers Unravel the Biology of a Distinct Prostate Cancer SubtypeJune 26th, 2019